These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 11083471)
1. Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: implications for gene therapy. Sat E; Leung KH; Bruckner-Tuderman L; Cheah KS Gene Ther; 2000 Oct; 7(19):1631-9. PubMed ID: 11083471 [TBL] [Abstract][Full Text] [Related]
2. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566 [TBL] [Abstract][Full Text] [Related]
3. Stable nonviral genetic correction of inherited human skin disease. Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Fang M; Calos MP; Khavari PA Nat Med; 2002 Oct; 8(10):1166-70. PubMed ID: 12244305 [TBL] [Abstract][Full Text] [Related]
4. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601 [TBL] [Abstract][Full Text] [Related]
5. cDNA cloning and chromosomal mapping of the mouse type VII collagen gene (Col7a1): evidence for rapid evolutionary divergence of the gene. Li K; Christiano AM; Copeland NG; Gilbert DJ; Chu ML; Jenkins NA; Uitto J Genomics; 1993 Jun; 16(3):733-9. PubMed ID: 8325648 [TBL] [Abstract][Full Text] [Related]
6. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Woodley DT; Keene DR; Atha T; Huang Y; Lipman K; Li W; Chen M Nat Med; 2004 Jul; 10(7):693-5. PubMed ID: 15195089 [TBL] [Abstract][Full Text] [Related]
8. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Kern JS; Loeckermann S; Fritsch A; Hausser I; Roth W; Magin TM; Mack C; Müller ML; Paul O; Ruther P; Bruckner-Tuderman L Mol Ther; 2009 Sep; 17(9):1605-15. PubMed ID: 19568221 [TBL] [Abstract][Full Text] [Related]
11. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176 [TBL] [Abstract][Full Text] [Related]
12. Recessive dystrophic epidermolysis bullosa caused by COL7A1 hemizygosity and a missense mutation with complex effects on splicing. Titeux M; Mejía JE; Mejlumian L; Bourthoumieu S; Mirval S; Tonasso L; Heller M; Prost-Squarcioni C; Hovnanian A Hum Mutat; 2006 Mar; 27(3):291-2. PubMed ID: 16470588 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations. van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875 [TBL] [Abstract][Full Text] [Related]
14. [Characterization of a canine model of dystrophic bullous epidermolysis (DBE). Development of a gene therapy protocol]. Magnol JP; Pin D; Palazzi X; Lacour JP; Gache Y; Meneguzzi G Bull Acad Natl Med; 2005 Jan; 189(1):107-19; discussion 119-21. PubMed ID: 16119884 [TBL] [Abstract][Full Text] [Related]
15. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants. Dang N; Klingberg S; Marr P; Murrell DF J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Chino T; Tamai K; Yamazaki T; Otsuru S; Kikuchi Y; Nimura K; Endo M; Nagai M; Uitto J; Kitajima Y; Kaneda Y Am J Pathol; 2008 Sep; 173(3):803-14. PubMed ID: 18688022 [TBL] [Abstract][Full Text] [Related]
18. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Dang N; Murrell DF Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993 [TBL] [Abstract][Full Text] [Related]
19. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa. Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease. Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]